Jiangsu CoWin Biotech Co., Ltd. engages in the research and development, production, and sale of biological products in China. The company provides molecular diagnostic raw material enzymes, nucleic acid collection and protection agents, nucleic acid extraction and purification kits, molecular diagnostic testing reagents, etc. It also offers medical device products, nucleic acid collection and protection, PCR, RT-PCR, and qPCR products, molecular diagnosis, isothermal amplification, nucleic acid mass spectrometry, next generation sequencing, nucleic acid extraction and purification, marker clone transfection, antibody, protein detection products, and scientific research instruments. The company was founded in 2010 and is headquartered in Taizhou, China.
Stock data | 2024 | Change |
---|---|---|
Price | $2.30 | N/A |
Market Cap | $258.67M | N/A |
Shares Outstanding | 112.23M | N/A |
Employees | 603.00 | N/A |